Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ha agreed. I honestly think them telegraphing hurts, because it gives shorts time to strategize and pick a point in the stock price when we’re up a certain amount (let’s say $25) to start creating FUD. If you buy at $18 knowing news is good and then the news comes out at and stock hits $25 then starts tanking, most short term guys want to sell at $22 or $21 before their profits are all gone
Talked about the same stuff last year. Same rhetoric, strong results came after. I think AHA is fine because it does draw interest. And in actuality, no one is going to sue him if results are sub par. He can just say excited to present and see my friends....but to rehash what was discussed last year, yes it seems weird and leading that amarin gives such positive vibes pre embargo unless they mean to totally telegraph.
I’m excited he’s presenting too...anyone is better than JT to present at this point! Let him run the company and other people present at conferences!
Last year they published results pre embargo as well. Just the exact info and topics are embargoed I think
Doesn’t bhatt man own him? I’d have to imagine if you’re a cardio in Boston, it’s not smart to pick something with bhatt? Or at least not to embarrass yourself in front of bhatt? I think this interview will be bullish
Ah makes sense. Thanks for clarifying
How do you know materials were shared?I thought that was coming early next week most likely?
Cantor Fitzgerald to hold a meeting on November 15th with an IP attorney to discuss Amarins patents. This will be a positive as their prior headline was “10/29 ruling a big positive for amarins generic case.”
Should be a good week for us!
Haven’t most of them sold shares before?
Looks like a morning share dump before the market buys amarin like it wants to. Maybe biotech researcher dumped the rest of his shares? Joking, but maybe another exec selling shares. Those 4 always seem to come out around the same time for multiple people
Yes my point is we should be up more from the outcome of yesterday. It is the first step towards a settlement/win. Couldn’t have hope for much better imo
Why not up more after court rulings? Lots of hedge fund guys I know thought biggest hurdle was genetics case. By end of January if were not well above highs something will be wrong. Need the genetics settled, not just fda. And yesterday we cleared a big hurdle with generics, getting our first little win in the case that should be over
Very weird. Again, the words were deducted a bit, but that’s how it’s quoted on BB. I will flag it as FUD
Sorry I get nervous actually taking screen pics or anything at work as it’s super against code, or I would for sure copy article. I don’t even access iHub on work comp
Amarin Judgement day for heart drug has 400% returns at stake
That was the name of the article on Bloomberg, probably can’t load it/take a pic but if you google that maybe something comes up?
Comment was amended on Bloomberg to some people disagree with amarins use of MO. Crazy that the first one could ever get published...
Yeah I wonder if they misquoted. Notice the quotation marks they used (I did it the exact same way they did). Hopefully no one is selling investors that MO was specifically against what the fda wanted
“The data themselves are good enough, but what I can’t account for is they basically went against the FDA” in using mineral oil, Jefferies health strategist Jared Holz said by telephone.
This was verbatim posted on Bloomberg news just now. This seems false right?
You know the good thing about the reporters and MRC? They have aired out all the possible things to knit pick, and amarin as prepared remarks for each publicly, and I’m sure privately in more depth. I hope they ask those questions you listed, but really could care less if they bring up MO or any other nonsense the haters have said.
The trial is so definitive and p value so low, nothing bad can come from questions/publicity. I just really hope bhatt is there to support us
North what are your thoughts on today’s SJ? I don’t have private messaging btw
Yeah no idea where this is coming from but sounds like a short. I think it will be the opposite...anyone super levered (shorts) will have to cover at least partial. I will go out on a limb and say the short share count will be half of what it is today or less come adcom.
If adcom goes well shorts will have to cover at or above all time highs imo. Who would sell below prior highs after a successful adcom and into, most likely, the unveiling of evaporate results which they seem to be hyping up for AHA. Not saying we’re a shoe in to be trading above here pre adcom, but nows probably an expensive time to be short (and margin will keep rising)
Yeah. Imo this is good. The slow burn for them until the rip up. Can’t wait for the shorts to get caught in a $20 gap up
Isn’t Lipitor equally preventative? That was bought for 60b or so and market was much less aggressive on multi billion buyouts then.
I think there is no price too high, but agree that at the time of BO it’s a function of the current stock price. It would be crazy for us to not be soaring above all time highs by end of Jan if all goes well
I think you mean 3.9m dollars if that’s what you’re talking about
Not really, I assume hedges. I can ask around about any trade particularly. In general, most hedge funds will spend a certain amount to hedge ore events. I wonder if bb buys puts...
I just see the cantor numbers look like there was a downtick in scripts. They don’t say the numbers, just show a graph
Seems scripts were down small this week, but probably from the Columbus Day weekend
That’s awesome. Love to see that they haven’t covered on this 20% uptick. Means they will have more to cover on next big catalyst! How can you buy 50m shares from people who don’t want to sell??
Yeah wanted to make sure after hours trading was still open, glad that didn’t move price down
Was this out all day or just for the last hour? And did they already know this or have they previously mentioned they were shooting for accelerated review in Europe?
I think lawsuits scare big pharma more than the fda tbh. I think we’ll see new highs only after court cases. We got big bad teva gone, now some chihuahuas to deal with
Yeah makes sense. I don’t think anyway we see BO until then. Unfortunate they are so stubborn
In general generics have nothing to lose and want to push the court case. If anything to set precedent haha
Seems like they’re not necessarily trying to settle, but still believe amarin will smash then in court in January. The generics haven’t done anything well, just delay tactics and reaching
I can see the cantor graphs they post every week. Doesn’t have the numbers but they look up for sure. I just search amarin on Bloomberg and the first thing says “scripts continue growth” so i think your theory is wrong
Scripts-
Didn’t have time to find exact numbers but looked at the graphs of growth cantor sent out and it looks like we had another positive week. Let’s keep it strong until adcom!
Comical he thinks the FDA would take his opinion seriously considering he’s short amarin and trying to sell reports to bash it. They want to hear citizens, not corporations who have a financial interest! What a joke
I’m confused by the 650m 2021 sales numbers. They almost imply smooth growth through 2030 which seems strange.
Even if peak sales is only 3b, I think by 2021, with fda and insurance cooperation, we’ll easily see over 1b in sales. That’s when we should get the biggest growth imo.
Article does not discuss the addressable market size nor mention the weekly/monthly growth % pre fda approval and European/international expansion. I think he’s late to the game so taking a contrarian stance.
Only upside is the biggest bear on the street has us up 12% in the next year
I don’t know. Kind of fits the profile. We’ve seen 2 sharmas bash amarin (one is an excommunicated doctor), and i suspect relation. Pyr and MRC also are just changing identity constantly. I think there’s a shot...
Either way, the more bullish articles the better! Glad he finally saw the light, for whatever reason
Any chance Steve giardino is sharma and he’s covering his ass publicly in case it all comes back to him? He was one of the bigger bears before adcom...not sure how late adcom announcement would make him a bull...
I tend to think it’s someone who’s short from $18 or $19 and is taking profits...covers a million shares that they’ve possibly made 5m on
Why would we need thero gone? Scripts are sky rocketing, he’s under promised and over delivered like any good CEO should, and has been straight forward with the shareholders. Thanks to him and current management, price has a high floor and we still have tons of international opportunities. Not sweating the months ahead and I have a bunch of shares haha